# Evaluating Simvastatin's Potential Role in Therapy

> **NCT00486044** · PHASE2 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 103 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Simvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00486044
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2019-03-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00486044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00486044, "Evaluating Simvastatin's Potential Role in Therapy". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00486044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*